91 related articles for article (PubMed ID: 8363219)
21. The effect of SM-8849 on experimental arthritis in mice.
Nagai H; Takaoka Y; Kuwabara K; Kamada H; Kitagaki K
Pharmacology; 1996 Jun; 52(6):377-86. PubMed ID: 8844788
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of a spontaneous arthritis in male DBA/1 mice after administration of monoclonal anti-idiotypic antibodies to a cross-reactive idiotope on anti-collagen antibodies.
Nordling C; Kleinau S; Klareskog L
Immunology; 1992 Sep; 77(1):144-6. PubMed ID: 1398761
[TBL] [Abstract][Full Text] [Related]
23. Restricted expression of anti-type II collagen antibody isotypes in mice suppressed for collagen-induced arthritis.
Kresina TF; Finegan CK
Ann Rheum Dis; 1986 Jan; 45(1):60-6. PubMed ID: 3954459
[TBL] [Abstract][Full Text] [Related]
24. Type II collagen-reactive T cell clones from mice with collagen-induced arthritis.
Dallman M; Fathman CG
J Immunol; 1985 Aug; 135(2):1113-8. PubMed ID: 2409139
[TBL] [Abstract][Full Text] [Related]
25. Identification of an immunosuppressive epitope of type II collagen that confers protection against collagen-induced arthritis.
Myers LK; Stuart JM; Seyer JM; Kang AH
J Exp Med; 1989 Dec; 170(6):1999-2010. PubMed ID: 2479704
[TBL] [Abstract][Full Text] [Related]
26. 15-Deoxyspergualin and mouse to rat heart retransplantation.
Gannedahl G; Karlsson-Parra A; Tötterman TH; Tufveson G
Transplant Proc; 1992 Apr; 24(2):710-1. PubMed ID: 1566493
[No Abstract] [Full Text] [Related]
27. Type II collagen induced arthritis in mice. V. The role of the spleen cell response in the immune and arthritogenic reaction to type II collagen.
Wooley PH; Whalen JD; Warner LM; Losten MK; Chapdelaine JM
J Rheumatol; 1989 Sep; 16(9):1192-6. PubMed ID: 2810274
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of type II collagen induced arthritis in mice by an immunosuppressive extract of Tripterygium wilfordii Hook f.
Gu WZ; Brandwein SR; Banerjee S
J Rheumatol; 1992 May; 19(5):682-8. PubMed ID: 1613695
[TBL] [Abstract][Full Text] [Related]
29. Effects of antiarthritic compounds on type II collagen-induced arthritis in rats.
Probert AW; Schrier DJ; Gilbertsen RB
Arch Int Pharmacodyn Ther; 1984 May; 269(1):167-76. PubMed ID: 6466005
[TBL] [Abstract][Full Text] [Related]
30. 15-Deoxyspergualin, an immunosuppressive agent, used in organ transplantation showed suppressive effects on malarial parasites.
Midorikawa Y; Haque QM
Chemotherapy; 1997; 43(1):31-5. PubMed ID: 8996739
[TBL] [Abstract][Full Text] [Related]
31. Immunosuppressive effects of FK 506 and 15-deoxyspergualin in rat lung transplantation.
Katayama Y; Takao M; Onoda K; Hiraiwa T; Yada I; Namikawa S; Kusagawa M
Transplant Proc; 1991 Feb; 23(1 Pt 1):349-53. PubMed ID: 1703690
[No Abstract] [Full Text] [Related]
32. Effect of a novel immunosuppressive agent, deoxyspergualin, on rejection in kidney transplant recipients.
Takahashi K; Ota K; Tanabe K; Oba S; Teraoka S; Toma H; Agishi T; Kawaguchi H; Ito K
Transplant Proc; 1990 Aug; 22(4):1606-12. PubMed ID: 2389420
[No Abstract] [Full Text] [Related]
33. Assessment of the anti-diabetic activity of deoxyspergualin in low-dose streptozotocin-induced diabetic mice.
Nemoto K; Sugawara Y; Takita T; Nakamura T; Takeuchi T
J Antibiot (Tokyo); 1988 Jan; 41(1):145-7. PubMed ID: 3346188
[No Abstract] [Full Text] [Related]
34. Experimental arthropathy induced in rhesus monkeys and DBA/1 mice by a novel method: intraperitoneal implantation of type II collagen adsorbed onto nitrocellulose filters.
Healy CT; Martin LN; Roberts ED; Rubin AS
Lab Invest; 1989 Mar; 60(3):462-70. PubMed ID: 2927084
[TBL] [Abstract][Full Text] [Related]
35. Deoxyspergualin: a new immunosuppressive drug for the treatment of auto-immune disease.
Nikolic-Paterson DJ; Kerr PG; Lan HY; Tesch GH; Atkins RC
Nephron; 1995; 70(4):391-6. PubMed ID: 7477641
[No Abstract] [Full Text] [Related]
36. Effects of cytogenin, a novel anti-arthritic agent, on type II collagen-induced arthritis in DBA/1J mice and adjuvant arthritis in Lewis rats.
Hirano S; Wakazono K; Agata N; Mase T; Yamamoto R; Matsufuji M; Sakata N; Iguchi H; Tone H; Ishizuka M
Int J Tissue React; 1994; 16(4):155-62. PubMed ID: 7797401
[TBL] [Abstract][Full Text] [Related]
37. Collagen-induced arthritis in mice. Localization of an arthritogenic determinant to a fragment of the type II collagen molecule.
Terato K; Hasty KA; Cremer MA; Stuart JM; Townes AS; Kang AH
J Exp Med; 1985 Aug; 162(2):637-46. PubMed ID: 2410532
[TBL] [Abstract][Full Text] [Related]
38. 15-Deoxyspergualin is a more potent and effective immunosuppressant than cyclosporine but does not effectively suppress lymphoproliferation in vivo.
Yuh DD; Morris RE
Transplant Proc; 1991 Feb; 23(1 Pt 1):535-9. PubMed ID: 1990605
[No Abstract] [Full Text] [Related]
39. Thalidomide therapy of established collagen-induced arthritis (CIA) not accompanied by an evident Th2 shift.
Hauschild A; Kroeger H; Mitchison NA; Ugrinovic S; Zwingenberger K
Clin Exp Immunol; 1997 Jun; 108(3):428-31. PubMed ID: 9182887
[TBL] [Abstract][Full Text] [Related]
40. IL-12 promotes cellular but not humoral type II collagen-specific Th 1-type responses in C57BL/6 and B10.Q mice and fails to induce arthritis.
Szeliga J; Hess H; Rüde E; Schmitt E; Germann T
Int Immunol; 1996 Aug; 8(8):1221-7. PubMed ID: 8918691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
